O. Reg. 264/04: GENERAL

 

ontario regulation 264/04

made under the

nursing act, 1991

Made: June 8, 2004
Approved: August 25, 2004
Filed: August 26, 2004
Printed in The Ontario Gazette: September 11, 2004

Amending O. Reg. 275/94

(General)

1. (1) Schedule 3 to Ontario Regulation 275/94 is amended by adding the following:

Acarbose – for renewal only

Alendronate sodium – for renewal only

Amantadine hydrochloride

Amlodipine besylate – for renewal only

Atenolol – for renewal only

Beclomethasone dipropionate (inhalation) – for renewal only

Budesonide – for renewal only 

Cefprozil 

Cefuroxime axetil (oral)

Celecoxib – for renewal only

Ciprofloxacin HC (otic)

Collagenase

Conjugated Estrogens

Conjugated Estrogens and medroxyprogesterone acetate

Cyanocobalamin (Vitamin B12)

Diltiazem – for renewal only

Enalapril maleate – for renewal only

Erythromycin ethylsuccinate/sulfisoxazole acetyl 

Estradiol-17 beta (micronized)

Estradiol-17 beta (transdermal)

Estradiol-17 beta (Silastic ring)

Estropipate (piperazine estrone sulfate) 

Estradiol-17 beta hemihydrate

Estradiol-17 beta norethindrone acetate 

Estrone (cone or cream)

Etidronate disodium/calcium carbonate – for renewal only

Fluconazole (oral) – for renewal only

Fluticasone propionate (inhalation) – for renewal only

Fluticasone propionate (nasal)

Formoterol fumarate dihydrate – for renewal only

Furosemide – for renewal only

Gentamicin sulphate (otic, ophthalmic and topical)

Gliclazide – for renewal only

Glyburide – for renewal only

Haloperidol – for chronic nausea in palliation

Hydrochlorothiazide – for renewal only

Hydrocortisone-17-valerate 

Imiquimod 

Ipatropium bromide – for renewal only

Ipatropium bromide/salbutamol sulfate – for renewal only

Ketoconazole (topical)

Levonorgestrel releasing intrauterine system

Levothyroxine sodium – for renewal only

Meloxicam – for renewal only

Metformin hydrochloride – for renewal only

Minocycline hydrochloride

Misoprostol

Mometasone furoate monohydrate 

Nifedipine – for renewal only

Norethindrone acetate/ethinyl estradiol 

Oseltamavir phosphate

Progesterone

Raloxifene HCL – for renewal only

Ramipril – for renewal only

Ranitidine HCL (oral)

Risedronate sodium hemi-pentahydrate – for renewal only

Rofecoxib – for renewal only

Salmeterol xinafoate – for renewal only

Salmeterol xinafoate/fluticasone propionate – for renewal only

Terbutaline sulfate – for renewal only

Tretinoin (topical)

Triamcinolone acetonide 

Trichloracetic acid 50-80% , Bichloracetic acid 50-80%

Zanamivir

(2) Schedule 3 to the Regulation is amended,

(a) by striking out “Lorazepam (injectable preparation) — in an emergency” and substituting “Lorazepam (injectable preparation and oral) — in an emergency”;

(b) by striking out “Medroxyprogesterone acetate (injectable preparation)” and substituting “Medroxyprogesterone acetate (injectable preparation and oral)”; and

(c) by striking out “Salbutamol (inhaler or nebulizer solution) — in an emergency” and substituting “Salbutamol (inhaler or nebulizer solution) — in an emergency or for renewal”.

Made by:

Council of the College of Nurses of Ontario:

Anne L. Coughlan

Executive Director

Sandra E. Ireland

President

Date made: June 8, 2004.